Evidence map›Paper›PMID 42555168›Full record

ArticleProtein science : a publication of the Protein Society2026

Facile, high-throughput protein purification enabled by high-efficiency protease elution.

Edson N Cárcamo Noriega, Ian S Truebridge, Frank D Teets, James W Bowman, Nathalia Rodriguez, Tessa A Howard, Christopher D Bahl

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Facile, high-throughput protein purification enabled by high-efficiency protease elution.Protein science : a publication of the Protein Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Edson N Cárcamo NoriegaAI Proteins, Inc., Boston, Massachusetts, USA.ORCID 0000-0003-1189-9077
Ian S TruebridgeAI Proteins, Inc., Boston, Massachusetts, USA.ORCID 0009-0004-5875-2552
Frank D TeetsAI Proteins, Inc., Boston, Massachusetts, USA.
James W BowmanAI Proteins, Inc., Boston, Massachusetts, USA.ORCID 0000-0002-2716-4668
Nathalia RodriguezAI Proteins, Inc., Boston, Massachusetts, USA.
Tessa A HowardAI Proteins, Inc., Boston, Massachusetts, USA.ORCID 0009-0004-3549-7050
Christopher D BahlAI Proteins, Inc., Boston, Massachusetts, USA.ORCID 0000-0002-3652-3693

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While advances in artificial intelligence have made protein design widely accessible, protein production and characterization remain a bottleneck. Protease-cleavable affinity tags are commonly used to improve yield and purity of recombinant proteins, but tag removal adds labor and complexity. Previous attempts to use a selective protease to elute cleaved fusion protein during affinity chromatography have suffered from poor digestion efficiency that greatly diminishes yield, or protease contamination in the eluate. Here, we describe a novel SUMO protease construct that supports rapid, high-yield protease elution. This is the keystone of an end-to-end DNA-to-protein workflow that we optimized for speed, parallelizability, and generalizability. While our workflow is intended for an automated liquid-handler, it can easily be performed manually, making it broadly accessible. We demonstrate the method by producing and characterizing 96 disparate proteins derived from mesophilic organisms. This provides a benchmark for methods development and a curated dataset useful for machine learning.

Indexed as

Chromatography, AffinityPeptide HydrolasesRecombinant Fusion ProteinsEscherichia coliPeptide HydrolasesRecombinant Fusion Proteinsaffinity chromatographyhigh‐throughputlaboratory automationprotein expressionprotein purificationrecombinant protein

Identifiers

PMID42555168
PMCPMC13440354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.